This study is testing an experimental procedure using intra-arterial verapamil in people who have had an acute ischemic stroke. Verapamil is a drug that treats vasospasm (spasm of a blood vessel). Researchers want to see if giving 10 mg or 20 mg of verapamil directly into an artery after a mechanical thrombectomy (a procedure to remove a blood clot) is safe and how it affects stroke recovery. You may be able to join if you are 18 to 80 years old, have had a recent ischemic stroke, and are a candidate for mechanical thrombectomy. The study will look at bleeding complications and serious adverse events, including death, at 3 months to understand the safety of this treatment. The current recruitment status is unclear.

Study design

This is an interventional study with a planned enrollment of 60 participants. Participants will be randomly assigned to receive either 10 mg or 20 mg of intra-arterial verapamil.

What's involved

Participants will receive intra-arterial verapamil following a mechanical thrombectomy procedure.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 3 months to monitor for bleeding complications and serious adverse events.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.